TCM
CGEM icon

Tang Capital Management’s Cullinan Oncology CGEM Stock Holding History

Tang Capital Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,121,138
Closed -$6.65M – 99
2025
Q3 		$6.65M Hold
1,121,138
– – 0.26% 85
2025
Q2 		$8.44M Hold
1,121,138
– – 0.43% 61
2025
Q1 		$8.49M Buy
1,121,138
+200,000
+22% +$1.92M 0.47% 52
2024
Q4 		$11.2M Hold
921,138
– – 0.74% 38
2024
Q3 		$15.4M Hold
921,138
– – 1.1% 29
2024
Q2 		$16.1M Buy
921,138
+350,000
+61% +$7.45M 1.64% 18
2024
Q1 		$9.73M Sell
571,138
-200,000
-26% -$3.09M 1.01% 34
2023
Q4 		$7.86M Buy
771,138
+150,000
+24% +$1.33M 0.73% 37
2023
Q3 		$5.62M Buy
621,138
+171,138
+38% +$1.78M 0.79% 39
2023
Q2 		$4.84M Sell
450,000
-50,000
-10% -$531K 0.71% 37
2023
Q1 		$5.12M Sell
500,000
-309,231
-38% -$3.41M 0.76% 39
2022
Q4 		$8.54M Buy
809,231
+185,215
+30% +$2.25M 1.24% 25
2022
Q3 		$8M Buy
624,016
+14,785
+2% +$199K 0.98% 31
2022
Q2 		$7.81M Buy
+609,231
New +$6.91M 1.19% 22

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Tang Capital Management's CGEM Position: Q4 2025 in Review

Tang Capital Management sold out of Cullinan Oncology (CGEM) in Q4 2025, closing a stake of 1,121,138 shares — an estimated $6.65M sold.

Tang Capital Management first reported a position in CGEM in Q2 2022 and held it in 14 quarters. The position peaked at $16.1M in Q2 2024. 153 funds tracked by Wall St. Rank hold CGEM as of Q4 2025.

  • Tang Capital Management reported no remaining Cullinan Oncology position as of Q4 2025 after selling out during the quarter.
  • Tang Capital Management sold 1,121,138 Cullinan Oncology shares in Q4 2025, an estimated $6.65M.
  • Tang Capital Management first reported a position in Cullinan Oncology in Q2 2022 and held it in 14 quarters.
  • Tang Capital Management's Cullinan Oncology position peaked at $16.1M in Q2 2024.
  • 153 funds tracked by Wall St. Rank held Cullinan Oncology as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.